Related Articles
suPAR, a soluble form of urokinase plasminogen activator receptor, inhibits human prostate cancer cell growth and invasion
Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis
Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients.
New ELISA for quantitation of human urokinase receptor (CD87) in cancer.
MicroRNA‑145 promotes the apoptosis of leukemic stem cells and enhances drug‑resistant K562/ADM cell sensitivity to adriamycin via the regulation of ABCE1